![Sherwin Sattarzadeh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sherwin Sattarzadeh
No open positions remaining
Net worth: 5 M $ as of 29/06/2026
Profile
Mr. Sherwin Sattarzadeh was previously employed as a Chief Executive & Operating Officer by Damora Therapeutics, Inc., a Chief Business Officer by Blueprint Medicines Corp., and a Director-Regulatory Affairs by Genzyme Corp.
He received his undergraduate degree from the University of British Columbia and an MBA from Boston University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/01/2026 | 190,376 ( 0.31% ) | 5 M $ | 29/06/2026 |
Former positions of Sherwin Sattarzadeh
| Companies | Position | End |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Chief Executive Officer | 29/03/2026 |
| BLUEPRINT MEDICINES CORPORATION | Human Resources Officer | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | General Counsel | 30/06/2015 |
Training of Sherwin Sattarzadeh
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
- Stock Market
- Insiders
- Sherwin Sattarzadeh
